Salvona Technologies

Executive Summary

Salvona Technologies is a specialized encapsulation company based in Dayton, Ohio, with over two decades of expertise in advanced drug delivery systems. The company's proprietary technologies enable precise control over release kinetics, stability enhancement, and targeted delivery of active ingredients, serving the pharmaceutical, nutraceutical, and cosmetic industries. By offering off-the-shelf encapsulations, custom development services, and turnkey formulation production, Salvona addresses a wide range of client needs, from early-stage R&D to commercial manufacturing. Its long-standing presence since 2002 underscores operational resilience and deep technical know-how in a competitive landscape. While the company remains private with no disclosed funding or valuation, its sustained operations and customer base suggest a stable, niche position in the drug delivery market. Salvona is well-positioned to benefit from the growing demand for improved bioavailability and targeted therapeutics, particularly as the pharmaceutical industry increasingly adopts advanced formulation technologies to enhance drug performance and patient compliance.

Upcoming Catalysts (preview)

• Q3 2026New Strategic Partnership with a Mid-Size Pharma60% success
• 2027Launch of Novel Encapsulation Platform for mRNA/RNA Therapeutics40% success
• Q1 2027Expansion into Biologics and Vaccine Adjuvant Formulations50% success